Farid Adrienne 4
4 · Century Therapeutics, Inc. · Filed Feb 21, 2024
Insider Transaction Report
Form 4
Farid Adrienne
Chief Operations Officer
Transactions
- Sale
Common Stock
2024-02-16$4.86/sh−485$2,358→ 114,149 total - Exercise/Conversion
Common Stock
2024-02-16$1.03/sh+485$500→ 114,634 total - Exercise/Conversion
Stock Option (right to buy)
2024-02-16−485→ 222,170 totalExercise: $1.03Exp: 2029-07-17→ Common Stock (485 underlying)
Footnotes (3)
- [F1]The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.85 to $4.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option is fully vested and exercisable.